The EuroVacc Foundation:
The EuroVacc, a Swiss non-profit making organisation created on November 22, 2002, has developed clinical and laboratory research facilities in Europe to bring European preventive HIV vaccines into clinical trials.

The Aims:
EuroVacc aims at developing prophylactic vaccines against human immunodeficiency virus and to promote world-wide accessibility to these vaccines

At a glance:
EuroVacc, based in Lausanne, is in the top tier of the global HIV/AIDS vaccine research effort.
Several HIV/AIDS vaccine candidates have been constructed with identical inserts, allowing meaningful comparison between the candidates. .